Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
66
MDT Quote, Financials, Valuation and Earnings
Last price:
$100.31
Seasonality move
:
1%
Day range:
$95.17 - $97.56
52-week range:
$79.55 - $106.33
Dividend yield:
2.91%
P/E ratio:
26.30x
P/S ratio:
3.61x
P/B ratio:
2.57x
Volume:
6.6M
Avg. volume:
6.3M
1-year change:
20.27%
Market cap:
$124.8B
Revenue:
$33.5B
EPS (TTM):
$3.70
Analysts' Opinion
-
Consensus RatingMedtronic Plc has received a consensus rating of Hold. The company's average rating is a Hold based on 12 Buy ratings, 15 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $110.97, Medtronic Plc has an estimated upside of 13.98% from its current price of $97.36.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $97.20 representing 0.16% downside risk from its current price of $97.36.
Fair Value
-
According to the consensus of 27 analysts, Medtronic Plc has 13.98% upside to fair value with a price target of $110.97 per share.
MDT vs. S&P 500
-
Over the past 5 trading days, Medtronic Plc has overperformed the S&P 500 by 0.04% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Medtronic Plc does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Medtronic Plc has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Medtronic Plc reported revenues of $9B.
Earnings Growth
-
Medtronic Plc has grown year-over-year earnings for 6 quarters straight. In the most recent quarter Medtronic Plc reported earnings per share of $1.07.
Enterprise value:
145.8B
EV / Invested capital:
1.87x
Price / LTM sales:
3.61x
EV / EBIT:
22.53x
EV / Revenue:
4.19x
PEG ratio (5yr expected):
2.03x
EV / Free cash flow:
28.01x
Price / Operating cash flow:
24.07x
Enterprise value / EBITDA:
15.37x
Gross Profit (TTM):
$20.8B
Return On Assets:
5.28%
Net Income Margin (TTM):
13.79%
Return On Equity:
9.84%
Return On Invested Capital:
6.21%
Operating Margin:
19.31%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Income Statement | ||||||
| Revenue | $32B | $33B | $34.8B | $8.4B | $9B | |
| Gross Profit | $19.2B | $19.8B | $20.8B | $5B | $5.4B | |
| Operating Income | $5.8B | $5.9B | $6.5B | $1.6B | $1.7B | |
| EBITDA | $8.5B | $8.6B | $9.5B | $2.3B | $2.5B | |
| Diluted EPS | $3.08 | $3.28 | $3.70 | $0.99 | $1.07 | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $22.7B | $25.4B | $22.1B | $22.4B | $24B | |
| Total Assets | $91.8B | $93.2B | $90.1B | $90B | $91.3B | |
| Current Liabilities | $7.8B | $14.5B | $9.7B | $12.2B | $9.9B | |
| Total Liabilities | $39.6B | $41.2B | $38.4B | $41.3B | $42.5B | |
| Total Equity | $52.2B | $52.1B | $51.6B | $48.7B | $48.9B | |
| Total Debt | $25.6B | $26.6B | $25.1B | $28.3B | $29.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $5.6B | $7.2B | $7.1B | $958M | $925M | |
| Cash From Investing | -$1.7B | -$2B | -$2.5B | -$345M | -$482M | |
| Cash From Financing | -$7.6B | -$5.1B | -$4.9B | -$534M | -$395M | |
| Free Cash Flow | $4B | $5.5B | $5.2B | $554M | $457M | |
MDT
Sector
Market Cap
$124.8B
$28.1M
Price % of 52-Week High
91.56%
50.9%
Dividend Yield
2.91%
0%
Shareholder Yield
3.26%
-1.55%
1-Year Price Total Return
20.27%
-19.36%
Beta (5-Year)
0.715
0.498
Dividend yield:
2.91%
Annualized payout:
$2.80
Payout ratio:
66.55%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$96.69
200-day SMA
Buy
Level
$91.33
Bollinger Bands (100)
Buy
Level
92.27 - 99.41
Chaikin Money Flow
Buy
Level
727.4M
20-day SMA
Sell
Level
$98.28
Relative Strength Index (RSI14)
Sell
Level
46.43
ADX Line
Sell
Level
19.44
Williams %R
Neutral
Level
-60.1818
50-day SMA
Sell
Level
$97.39
MACD (12, 26)
Sell
Level
-0.69
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Neutral
Level
3.6B
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7138)
Buy
CA Score
(Annual)
Level (0.174)
Buy
Beneish M-Score
(Annual)
Level (-2.5748)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-2.0583)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Stock Forecast FAQ
In the current month, MDT has received 12 Buy ratings 15 Hold ratings, and 0 Sell ratings. The MDT average analyst price target in the past 3 months is $110.97.
-
Where Will Medtronic Plc Stock Be In 1 Year?
According to analysts, the consensus estimate is that Medtronic Plc share price will rise to $110.97 per share over the next 12 months.
-
What Do Analysts Say About Medtronic Plc?
Analysts are divided on their view about Medtronic Plc share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Medtronic Plc is a Sell and believe this share price will drop from its current level to $97.20.
-
What Is Medtronic Plc's Price Target?
The price target for Medtronic Plc over the next 1-year time period is forecast to be $110.97 according to 27 Wall Street analysts, 12 of them rate the stock a Buy, 0 rate the stock a Sell, and 15 analysts rate the stock a Hold.
-
Is MDT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Medtronic Plc is a Hold. 15 of 27 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MDT?
You can purchase shares of Medtronic Plc via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Medtronic Plc shares.
-
What Is The Medtronic Plc Share Price Today?
Medtronic Plc was last trading at $100.31 per share. This represents the most recent stock quote for Medtronic Plc. Yesterday, Medtronic Plc closed at $97.36 per share.
-
How To Buy Medtronic Plc Stock Online?
In order to purchase Medtronic Plc stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get MDT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MDT
Sector
P/E ratio
26.30x
24.09x
PEG ratio
2.03x
-0.01x
P/B ratio
2.57x
1.83x
Price / LTM sales
3.61x
1.59x
Growth Metrics
MDT
Sector
Revenue growth
6.64%
4.68%
Earnings growth
8.1%
10.88%
Revenue (5-year growth)
3.01%
6.45%
Earnings forecast
$1.31
-$0.18
Profitability
MDT
Sector
Profitability FY 2025
$20.1B
$3.6M
Return on invested capital
6.21%
-31.87%
Return on assets
5.28%
-28.18%
Return on equity
9.84%
-37.89%
Earnings Date
Last Earnings Date
Nov
18
Next Earnings Date
Feb
17
Estimated Next Earnings Date
Feb
17
Balance Sheet
MDT
Sector
Total cash
$8.3B
$26.2M
Short term investments
$6.7B
$25.7M
Total assets
$91.7B
$76.7M
Long term debt
$29.1B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 36x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
64
RGC alert for Jan 6
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Buy
73
INOD alert for Jan 6
Innodata, Inc. [INOD] is up 4.84% over the past day.
Buy
65
AVAV alert for Jan 6
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
